$300,000 raised - and we’re not slowing down.
We’re incredibly proud to share that Pulse Tile™ has now surpassed the $300K milestone.
Thank you to every investor who has backed the mission so far.
While the raise has been live, we’ve continued to build real momentum behind the scenes:
- We’ve onboarded an additional engineer with deep experience in MedTech sensor development, having recently supported Headsafe through to commercialisation
- We’ve progressed a meaningful collaboration with a state ambulance service, who are preparing to provide a formal letter of endorsement - and have also indicated interest in including Pulse Tile™ in clinical trials this year
- We’ve gathered valuable data from our large animal study at the Baker Institute, helping inform the design of our first-in-human clinical trials
- We’ve become eligible for the TTRA medical device grant, supporting future development and commercialisation
- We’ve conducted early health economics analysis, demonstrating the potential for Pulse Tile™ to reduce unnecessary callouts and deliver cost savings for ambulance services and first responder organisations
This is exactly the kind of progress your investment helps make possible.
With just 2 days remaining, we’re focused on finishing strong and continuing to build momentum into the next phase.
If you’ve been considering investing, now is the time.
Always consider the general CSF risk warning and offer document before investing.